Back to Search Start Over

The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial.

Authors :
Nordlund, J
Henry, RS
Kwakkenbos, L
Carrier, M-E
Levis, B
Nielson, WR
Bartlett, SJ
Dyas, L
Tao, L
Fedoruk, C
Nielsen, K
Hudson, M
Pope, J
Frech, T
Gholizadeh, S
Johnson, SR
Piotrowski, P
Jewett, LR
Gordon, J
Chung, L
Bilsker, D
Levis, AW
Turner, KA
Cumin, J
Welling, J
Fortuné, C
Leite, C
Gottesman, K
Sauve, M
Rodríguez-Reyna, TS
Larche, M
van Breda, W
Suarez-Almazor, ME
Wurz, A
Culos-Reed, N
Malcarne, VL
Mayes, MD
Boutron, I
Mouthon, L
Benedetti, A
Thombs, BD
SPIN Investigators
Nordlund, J
Henry, RS
Kwakkenbos, L
Carrier, M-E
Levis, B
Nielson, WR
Bartlett, SJ
Dyas, L
Tao, L
Fedoruk, C
Nielsen, K
Hudson, M
Pope, J
Frech, T
Gholizadeh, S
Johnson, SR
Piotrowski, P
Jewett, LR
Gordon, J
Chung, L
Bilsker, D
Levis, AW
Turner, KA
Cumin, J
Welling, J
Fortuné, C
Leite, C
Gottesman, K
Sauve, M
Rodríguez-Reyna, TS
Larche, M
van Breda, W
Suarez-Almazor, ME
Wurz, A
Culos-Reed, N
Malcarne, VL
Mayes, MD
Boutron, I
Mouthon, L
Benedetti, A
Thombs, BD
SPIN Investigators
Publication Year :
2021

Abstract

BACKGROUND: Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. We completed an initial feasibility trial of an online self-administered version of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program using the cohort multiple randomized controlled trial (RCT) design. Due to low intervention offer uptake, we will conduct a new feasibility trial with progression to full-scale trial, using a two-arm parallel, partially nested RCT design. The SPIN-SELF Program has also been revised to include facilitator-led videoconference group sessions in addition to online material. We will test the group-based intervention delivery format, then evaluate the effect of the SPIN-SELF Program on disease management self-efficacy (primary) and patient activation, social appearance anxiety, and functional health outcomes (secondary). METHODS: This study is a feasibility trial with progression to full-scale RCT, pending meeting pre-defined criteria, of the SPIN-SELF Program. Participants will be recruited from the ongoing SPIN Cohort ( http://www.spinsclero.com/en/cohort ) and via social media and partner patient organizations. Eligible participants must have SSc and low to moderate disease management self-efficacy (Self-Efficacy for Managing Chronic Disease (SEMCD) Scale score ≤ 7.0). Participants will be randomized (1:1 allocation) to the group-based SPIN-SELF Program or usual care for 3 months. The primary outcome in the full-scale trial will be disease management self-efficacy based on SEMCD Scale scores at 3 months post-randomization. Secondary outcomes include SEMCD scores 6 months post-randomization plus patient activation, social appearance anxiety, and functional health outcomes at 3 and 6 months post-randomization. We will include 40 participants to assess feasibility. At the end of the feasibility portion, stoppage criteria will be used to determine if the trial procedures or SPIN-SELF Program need important

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1373000191
Document Type :
Electronic Resource